2nd Quarter - Report

AVOQ, LLC for GINGKO BIOWORKS

Period 2nd Quarter 2021 Filed Jul 20, 2021 Signed by Steven Elmendorf

Official filing
Firm
AVOQ, LLC
Client
GINGKO BIOWORKS
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Science/Technology SCI

Issues relating to synthetic biology

LobbyistCovered position, as disclosed
STEVEN ELMENDORF —
BILL GHENT —
SHANTI STANTON —

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues relating to synthetic biology

LobbyistCovered position, as disclosed
STEVEN ELMENDORF —
BILL GHENT —
SHANTI STANTON —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.